Personal information

No personal information available

Activities

Works (23)

Views of research ethics committee members on end-of-participation communications for trial participants who stop taking part: a cross-sectional survey study

Trials
2024-09-30 | Journal article
Contributors: William J. Cragg; Liam Bishop; Rachael Gilberts; Michael Gregg; Mary Mancini; Clara Martins de Barros
Source: check_circle
Crossref

Views of research ethics committee members on end-of-participation communications for trial participants who stop taking part: a cross-sectional survey study.

2024-06-10 | Preprint
Contributors: William Cragg; Liam Bishop; Rachael Gilberts; Michael Gregg; Mary Mancini; Clara Martins de Barros
Source: check_circle
Crossref

Approaches and experiences implementing remote, electronic consent at the Leeds Clinical Trials Research Unit

Trials
2024-05-08 | Journal article
Contributors: William J Cragg; Chris Taylor; Lauren Moreau; Howard Collier; Rachael Gilberts; Niamh McKigney; Joanna Dennett; Sandra Graca; Ian Wheeler; Liam Bishop et al.
Source: check_circle
Crossref

How can we support research participants who stop taking part? Communications guidance developed through public-researcher collaboration

Research Involvement and Engagement
2024-04-18 | Journal article
Contributors: William J. Cragg; Liam Bishop; Rachael Gilberts; Michael Gregg; Terry Lowdon; Mary Mancini; Clara Martins de Barros; Pete Wheatstone
Source: check_circle
Crossref

Site staff perspectives on communicating trial results to participants: Cost and feasibility results from the Show RESPECT cluster randomised, factorial, mixed-methods trial

Clinical Trials
2023-12 | Journal article
Contributors: Annabelle South; Julia Bailey; Barbara E Bierer; Eva Burnett; William J Cragg; Carlos Diaz-Montana; Katie Gillies; Talia Isaacs; Nalinie Joharatnam-Hogan; Claire Snowdon et al.
Source: check_circle
Crossref

Approaches and experiences implementing remote, electronic consent at the Leeds Clinical Trials Research Unit

2023-12-12 | Preprint
Contributors: William Cragg; Chris Taylor; Lauren Moreau; Howard Collier; Rachael Gilberts; Niamh McKigney; Joanna Dennett; Sandra Graca; Ian Wheeler; Liam Bishop et al.
Source: check_circle
Crossref

Developing an online, searchable database to systematically map and organise current literature on retention research (ORRCA2)

Clinical Trials
2022-02 | Journal article
Contributors: Anna Kearney; Polly-Anna Ashford; Laura Butlin; Thomas Conway; William J Cragg; Declan Devane; Heidi Gardner; Daisy M Gaunt; Katie Gillies; Nicola L Harman et al.
Source: check_circle
Crossref

Clinical trial recruiters’ experiences working with trial eligibility criteria: results of an exploratory, cross-sectional, online survey in the UK

Trials
2021-12 | Journal article
Contributors: William J. Cragg; Kathryn McMahon; Jamie B. Oughton; Rachel Sigsworth; Christopher Taylor; Vicky Napp
Source: check_circle
Crossref

Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial

PLOS Medicine
2021-10-04 | Journal article
Contributors: Annabelle South; Aaron S. Kesselheim; Nalinie Joharatnam-Hogan; Cara Purvis; Elizabeth C. James; Carlos Diaz-Montana; William J. Cragg; Conor Tweed; Archie Macnair; Matthew R. Sydes et al.
Source: check_circle
Crossref

Clinical Trial Recruiters’ Experiences Working With Trial Eligibility Criteria: Results of an Exploratory, Cross-sectional, Online Survey

2021-08-26 | Preprint
Contributors: William Cragg; Kathryn McMahon; Jamie B Oughton; Rachel Sigsworth; Christopher Taylor; Vicky Napp
Source: check_circle
Crossref

Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review

Clinical Trials
2021-04 | Journal article
Contributors: William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Source: check_circle
Crossref

Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMPER triggered monitoring study

Clinical Trials
2021-02 | Journal article
Contributors: William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Source: check_circle
Crossref

Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: further analyses of findings from the prospective TEMPER triggered monitoring study

2020-04-07 | Other
Contributors: William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Source: check_circle
Crossref

Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: a scoping review

2020-04-06 | Other
Contributors: William J Cragg; Caroline Hurley; Victoria Yorke-Edwards; Sally P Stenning
Source: check_circle
Crossref

A third trial oversight committee: Functions, benefits and issues

Clinical Trials
2020-02-30 | Journal article
Contributors: J Athene Lane; Carrol Gamble; William J Cragg; Doreen Tembo; Matthew R Sydes
Source: check_circle
Crossref

Early warnings and repayment plans: novel trial management methods for monitoring and managing data return rates in a multi-centre phase III randomised controlled trial with paper Case Report Forms

Trials
2019-12 | Journal article
Contributors: William J. Cragg; Fay Cafferty; Carlos Diaz-Montana; Elizabeth C. James; Johnathan Joffe; Monica Mascarenhas; Victoria Yorke-Edwards
Source: check_circle
Crossref

Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system

Trials
2019-12 | Journal article
Contributors: Carlos Diaz-Montana; William J. Cragg; Rahela Choudhury; Nicola Joffe; Matthew R. Sydes; Sally P. Stenning
Source: check_circle
Crossref

Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate

BMJ Open
2019-09 | Journal article
Contributors: Tim P Morris; Christopher I Jarvis; William Cragg; Patrick P J Phillips; Babak Choodari-Oskooei; Matthew R Sydes
Source: check_circle
Crossref

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study

Clinical Trials
2018-12 | Journal article
Contributors: Sally P Stenning; William J Cragg; Nicola Joffe; Carlos Diaz-Montana; Rahela Choudhury; Matthew R Sydes; Sarah Meredith
Source: check_circle
Crossref

When participants get involved: reconsidering patient and public involvement in clinical trials at the MRC Clinical Trials Unit at UCL.

Trials
2018-02 | Journal article
Contributors: Vale CL; Cragg WJ; Cromarty B; Hanley B; South A; Stephens R; Sturgeon K; Gafos M
Source: Self-asserted source
William Cragg via Europe PubMed Central

Erratum to: 'Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies'.

Trials
2016 | Journal article
Contributors: South A; Hanley B; Gafos M; Cromarty B; Stephens R; Sturgeon K; Scott K; Cragg WJ; Tweed CD; Teera J et al.
Source: Self-asserted source
William Cragg via Europe PubMed Central

Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies.

2016 | Journal article
Contributors: South A; Hanley B; Gafos M; Cromarty B; Stephens R; Sturgeon K; Scott K; Cragg WJ; Tweed CD; Teera J et al.
Source: Self-asserted source
William Cragg via Europe PubMed Central

Molecular diversity and evolutionary history of rabies virus strains circulating in the Balkans.

2011-09 | Journal article
Contributors: McElhinney LM; Marston DA; Freuling CM; Cragg W; Stankov S; Lalosevic D; Lalosevic V; Müller T; Fooks AR
Source: Self-asserted source
William Cragg via Europe PubMed Central

Peer review (27 reviews for 5 publications/grants)

Review activity for BMC medicine (1)
Review activity for Contemporary clinical trials. (3)
Review activity for Research involvement and engagement. (2)
Review activity for Therapeutic innovation & regulatory science. (7)
Review activity for Trials (14)